Amani Therapeutics: Funding, Investors & Team (Aug 2026)
Amani Therapeutics is breaking down barriers with breakthrough technology to provide effective medicines for those suffering from significant psychiatric illnesses, restoring hope and stability and allowing them to live more fulfilling lives.
Amani Therapeutics has raised $25.0M across 1 funding round on record, the most recent a Series A of $25.0M announced in Mar 2026.
That round is above the $3.0M median round size for Other companies tracked on FundedIQ over the last two years.
Amani Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Amani Therapeutics Funding Rounds
Amani Therapeutics Founders and Leadership Team
Contact details for the Amani Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →Amani Therapeutics Funding Compared to Other Other Startups
Amani Therapeutics' latest round of $25.0M is above the median round in Other. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Amani Therapeutics in Other and New York
Companies Similar to Amani Therapeutics
RockRose Risk is a captive underwriting manager and insurance broker with a focus on risk-reduction plans for…
A truly new way to drink water. Kara Pure turns air into water, literally. No installation, no 5-gallon jugs,…
NALA Systems provides environmental services. New reverse osmosis membranes are what the industry has been…
AI for the Built World. We accelerate the world’s most important projects from concept to completion and…
Older Adults Technology Services develops programs to assist seniors in studying and using technology.
Abacus Employment Services supporting Permanent & Temporary recruitment in the Industrial, Distribution,…
Habitat For Humanity of Greater Charlottesville creates housing with the help of volunteers for the…
The Dallas Foundation is a non-profit organization.
Web Search Engine
First Mutual Holding Co. (FMHC) is a member-owned holding company headquartered in Ohio. FMHC provides a…
Direct message your customers.
Nortiva Bio is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts, that is…
Amani Therapeutics Funding FAQs
What does Amani Therapeutics do?
Amani Therapeutics is breaking down barriers with breakthrough technology to provide effective medicines for those suffering from significant psychiatric illnesses, restoring hope and stability and allowing them to live more fulfilling lives.
How much funding has Amani Therapeutics raised?
Amani Therapeutics has raised $25.0M across 1 round on record. The most recent is a Series A of $25.0M announced in Mar 2026.
When did Amani Therapeutics last raise funding?
Amani Therapeutics' most recent funding round on record is a Series A of $25.0M, announced in Mar 2026.
Who founded Amani Therapeutics?
FundedIQ lists Jon Amani (Founder) at Amani Therapeutics.
Where is Amani Therapeutics headquartered?
Amani Therapeutics is based in New York, New York, United States.
How many employees does Amani Therapeutics have?
Amani Therapeutics is in the 11-50 employee band.
How does Amani Therapeutics' funding compare to other Other startups?
Amani Therapeutics' latest round of $25.0M is above the $3.0M median round size for Other companies on FundedIQ across 1,391 tracked companies over the last two years.
About FundedIQ's Amani Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Amani Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.